AI Layoffs May Fuel Future Hiring
The recent wave of AI-driven layoffs may be temporary, according to new analysis. Gartner suggests half of firms cutting jobs will be rehiring by 2027 for roles that augment human engineers with AI. This is echoed by a Deloitte report showing a move toward hybrid teams over pure automation.
While the tech industry has seen significant job cuts, with around 127,000 workers laid off from U.S.-based tech companies in 2025, the demand for AI-specific roles is surging. Job postings requiring AI literacy skills grew by over 70% year-over-year, indicating a clear shift in the desired skill set. This trend is underscored by the fact that workers with AI skills can command a wage premium of up to 56%. The nature of software engineering roles is evolving from manual coding to higher-level system design and architecture. Companies are increasingly using AI for entry-level tasks, which has led to a decrease in junior developer roles but a 40% explosion in demand for machine learning engineers in 2025. The most in-demand technical skills now include Python, machine learning, large language models (LLMs), and MLOps. This industry shift is creating entirely new job categories. Roles like AI Trainer, AI Ethicist, and AI Auditor are emerging to support the responsible development and deployment of artificial intelligence. The demand for these specialized roles is expected to grow as AI becomes more integrated into business operations. In Los Angeles, a growing hub for tech and AI, startups are actively hiring for roles in these emerging fields. Companies like Virtualitics, Metropolis, and AE Studio are developing AI-powered solutions for data analytics, mobility, and software development. This local ecosystem provides opportunities for graduating students to engage with cutting-edge AI applications. The fintech and biotech sectors are also heavily investing in AI talent. In fintech, AI is being used for fraud detection, algorithmic trading, and personalized customer experiences. Biotech firms like Insilico Medicine and Recursion Pharmaceuticals are leveraging AI to accelerate drug discovery and analyze complex biological data. These applications highlight the real-world impact of AI and the demand for engineers who can build these systems.
